logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Tranexamic Acid CAS 1197-18-8

Tranexamic Acid CAS 1197-18-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1197-18-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: D/P,L/C,D/A,T/T,MoneyGram,Western Union

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
1197-18-8
Appearance::
White Crystalline Powder
Molecular Formula::
C8H15NO2
Molecular Weight::
157.21000
EINECS NO::
214-818-2
MDL NO::
MFCD00001466
CAS NO::
1197-18-8
Appearance::
White Crystalline Powder
Molecular Formula::
C8H15NO2
Molecular Weight::
157.21000
EINECS NO::
214-818-2
MDL NO::
MFCD00001466
Tranexamic Acid CAS 1197-18-8

Product Description:

Product Name: Tranexamic acid CAS NO: 1197-18-8


Synonyms:

Tranexamic acid;

Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-;

trans-4-(Aminomethyl)cyclohexanecarboxylic acid;


Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.00%

Density: 1.096g/cm3

Boiling Point: 300.201℃ at 760 mmHg

Melting Point: 300℃

Flash Point: 135.357℃

Refractive Index: 1.497

Stability: Stable at room temperature in closed containers under normal storage and handling conditions.

Storage Condition: Refrigerator

Vapor Pressure: 0mmHg at 25℃


Safety Information:

Hazard Class: 3

Safety Statements: S26; S36; S37/39

HS Code: 2922499990

WGK Germany: 2

Packing Group: II

RIDADR: UN 1993 3/PG 2

Risk Statements: R36/37/38

Hazard Code: Xi


Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from trauma, surgery, and in various medical conditions including hemophilia and heavy menstrual bleeding. It comes in oral and intravenous forms.

Side effects are uncommon and include gastrointestinal effects, dizziness, fatigue, headache, and hypersensitivity reactions. The medication needs to be used cautiously in people with kidney disease and who are at a high risk for blood clots. Tranexamic is safe to use in pregnant women. However, caution should be used in lactating women. It is an antifibrinolytic.

It was discovered in 1962 by Utako Okamoto and has been on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.